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Abstract 
Aim: We aimed to determine the prognostic accuracy of the Basel Screening Instrument 
for Psychosis (BSIP) in terms of specificity, sensitivity, positive and negative predictive 
value by following up individuals that were initially not considered to be at increased 
risk of psychosis based on the BSIP. Moreover, clinical characteristics of these 
individuals were examined given the relative lack of such information in the literature.  
Methods: As part of the “Früherkennung von Psychosen” (FePsy) study, 87 individuals 
were screened with the BSIP. Of these, 64 were classified at baseline as being in an at-
risk mental state (ARMS+) for psychosis using the BSIP and followed up at regular 
time intervals for at least two years to determine a putative transition to psychosis. 
Twenty-three individuals were classified at baseline as not being in an at-risk mental 
state (ARMS–) using the BSIP and re-assessed after four years. Sensitivity, specificity, 
positive and negative predictive value of the BSIP were computed. Clinical 
characteristics of the ARMS– group were analysed descriptively. 
Results: During the follow-up period, none of the ARMS– individuals, but 21 of 
ARMS+ had developed psychosis. Sensitivity of the BSIP was 1.0, specificity was 0.35. 
The majority of ARMS– individuals showed depressive disorders or anxiety disorders 
and varying levels of functioning. 
Conclusions: The BSIP has good prognostic accuracy for detecting the prodromal 
phase of psychosis with an excellent sensitivity and a specificity similar to other risk 
instruments and the advantage of a relatively short duration. Depressive and anxiety 
symptoms commonly develop in ARMS– individuals. 
Key words: prodromal, psychosis, screening instrument, sensitivity, specificity 
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Introduction 
The prodromal period of psychosis has received major attention as it holds the potential 
for early intervention which is considered key to significantly improve prognosis and 
functional outcome.1 One of the ultimate goals in early detection of psychosis research 
is to detect the prodromal stage, offer treatment and thus delay or prevent the actual 
onset of illness.2 Accordingly, several clinical instruments have been developed to 
identify individuals suspected to be in the prodromal phase of psychosis.3-6 These 
individuals are considered to be in an “at-risk mental state” (ARMS) for the disease. 
The diagnostic category “attenuated psychosis syndrome” (APS) capturing prepsychotic 
symptoms has even been proposed for inclusion into the fifth edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-5).7 However, several concerns have 
been raised that ultimately led to its inclusion in the research section as a condition for 
further study only. Among these, the validity of the ARMS concept has been 
questioned.8 Given the relatively non-specific nature of early prodromal symptoms and 
their considerable overlap in symptomatology with depression,9 the prospective clinical 
assessment of the prodromal period of psychosis is complicated by high rates of false-
positives. Only about 36% of individuals meeting ARMS criteria go on to develop 
psychosis within three years.10 Moreover, about one third of ARMS individuals appear 
to remit from their initial risk status.11 Accordingly, concerns have been raised that the 
ARMS may lead to unnecessary treatment, stigma and discrimination of what might be 
a self-limiting phase.12  
On the other hand, relatively little attention has been paid to the issue of false-
negatives.13 Incorrect classification of individuals as being not at increased psychosis 
risk may also have severe consequences for the individuals concerned, including a delay 
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of adequate treatment. Recently, attempts have started to follow-up these individuals in 
order to examine a putative onset of psychosis and thus assess the prognostic accuracy 
of clinical instruments.14 Also, clinical characteristics of individuals initially classified 
as being not at increased risk of psychosis after a considerable follow-up period are 
lacking. 
Commonly used clinical instruments to identify ARMS individuals include the 
Comprehensive Assessment of At Risk Mental States (CAARMS),3 the Structured 
Interview for Prodromal Syndromes (SIPS),4 the Schizophrenia Proneness Instrument 
(SPI-A)5 and the Basel Screening Instrument for Psychosis (BSIP).6 This study focusses 
on the BSIP which has been shown to have a predictive validity comparable to other 
established clinical instruments,15 with 32% of ARMS individuals developing psychosis 
within a follow-up period of up to five years.6 Moreover, a very good inter-rater 
reliability has been demonstrated (Kappa .87).6 However, the sensitivity and specificity 
of the BSIP have not been determined as yet since only ARMS individuals had initially 
been followed up.  
Therefore, we invited individuals not meeting ARMS criteria according to the BSIP to a 
follow-up appointment and assessed whether psychosis had occurred. Moreover, we 
examined their clinical and functional outcome in terms of general wellbeing, 
psychopharmacological or psychotherapeutic treatments, psychopathological symptoms, 
mental disorders, capacity to work and global functioning. Based on our previous 
investigations,6 we hypothesized that the BSIP identifies with high sensitivity and 
moderate specificity individuals at increased risk of psychosis. Accordingly, we 
expected that none of the individuals not meeting ARMS criteria during the initial 
screening had subsequently developed psychosis. Second, we hypothesized that these 
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individuals fulfil criteria for various mental disorders and present with varying degrees 
of functional outcome as typically observed in mixed patient samples.  
 
Methods 
Setting and Recruitment 
Participants were initially recruited between 01/03/2000 and 28/02/2007 as part of the 
prospective “Früherkennung von Psychosen” (FePsy; English: Early detection of 
psychosis) study. A detailed description of the study design can be found elsewhere.16, 17 
In brief, individuals suspected to be in their early (prodromal) phase of psychosis were 
referred to our specialised early detection clinic at the Psychiatric University Outpatient 
Department of the Psychiatric University Clinics Basel, Switzerland. This study was 
approved by the Ethics Committee Basel (EKBB) and conforms to the provisions of the 
Declaration of Helsinki. For the telephone interview, consent was obtained orally. In all 
individuals attending an outpatient appointment, written informed consent was obtained. 
 
Initial Screening with the Basel Screening Instrument for Psychosis 
Individuals were screened with the BSIP which has been designed to identify 
individuals presenting with putative prodromal symptoms or full-blown (first-episode) 
psychosis.6, 18 It consists of seven sections that capture prodromal symptoms as 
specified in the revised third edition of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-III-R),19 other early psychosis symptoms as derived from the literature, 
and current or previous (pre)psychotic symptoms as defined by Yung and colleagues.20 
Moreover, known risk factors such as young age, social decline, familial aggregation of 
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psychotic disorders, previous psychiatric history and referral because of suspected 
psychosis are taken into account (Table 1). The interview duration of the BSIP varies 
between 45-60 minutes. 
 
[Insert Table 1] 
 
Individuals were classified as being in an ARMS if they met one of the following 
inclusion criteria: (a) attenuated or brief limited psychotic symptoms according to the 
criteria by Yung et al.;20 (b) familial aggregation of psychotic disorders in combination 
with at least two further risk factors according to screening instrument in line with the 
criteria by Yung et al.;20 (c) a minimal amount and combination of certain risk factors 
according to screening instrument (for details, see 16). Individuals meeting criteria (a) or 
(b) are considered at particular “high risk” because they show more psychosis-related 
symptoms or risk factors, whilst individuals meeting criteria (c) are considered at “low 
risk” as their symptoms are rather nonspecific.  
On the basis of the BSIP, individuals were classified as either being in an ARMS 
(ARMS+ group), having an established (first-episode) psychosis, or being not at 
increased risk of psychosis (ARMS– group). ARMS+ and first-episode psychosis (FEP) 
individuals were invited to take part in the FePsy study, provided that they did not meet 
any exclusion criteria described previously.6 For this study, ARMS– subjects were re-
contacted approximately four years after their initial appointment at our clinic and 
invited to take part in a follow-up assessment. 
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Follow-up and Transition to Psychosis  
ARMS+ individuals were re-assessed at regular time intervals for at least two years to 
examine whether transition to psychosis had occurred. ARMS– individuals were 
interviewed by telephone and subsequently invited to a face-to-face clinical interview at 
our clinic. Transition to psychosis was examined based on the Brief Psychiatric Rating 
Scale (BPRS)21 items “suspiciousness”, “unusual thought content”, “hallucinations” and 
“conceptual disorganization”, using the criteria of Yung et al.20 
 
Follow-up Telephone Interview of Individuals Not at Risk of Psychosis 
During the telephone interview, general wellbeing, capacity to work and 
psychopharmacological or psychotherapeutic treatments received since the initial 
screening were assessed. Transition to psychosis was examined based on the BPRS as 
described above. These items have shown good inter-rater reliability during a telephone 
interview before.22 
 
Follow-up Face-to-Face Clinical Interview of Individuals Not at Risk of Psychosis 
In those individuals who agreed to face-to-face assessments, the BPRS was 
administered to assess overall symptoms and transition to psychosis. Current diagnoses 
were assessed using the Structured Clinical Interview for Axis-I Disorders23 and Axis-II 
Disorders (SCID).24 Overall level of functioning was examined using the Global 
Assessment of Functioning (GAF).24  
Subjectively experienced (pre)psychotic symptoms were assessed with self-rating 
questionnaires. The Paranoid Scale of the Paranoid-Depression Scale (PDS)25 was used 
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to examine suspiciousness and loss of contact with reality. A global paranoid score was 
calculated, ranging from 0 to 48. Scores greater than 5 were considered an indicator for 
a potential loss of contact with reality.25  
The Symptom Checklist (SCL-90-R)26 was administered to assesses subjective 
impairment caused by “paranoid ideation” and “psychoticism”. Average "paranoid 
ideation" and "psychoticism" scores were determined, ranging between 0 and 4. Scores 
exceeding 1.89 and 1.48, respectively, were considered indicators of full-blown 
psychosis since they were one standard deviation above the average score typically 
found in non-psychotic psychiatric patients.25  
Finally, positive and negative symptom dimensions as of the Community Assessment of 
Psychic Experiences (CAPE)27 were assessed, with total scores ranging from 2 to 8. For 
the positive dimension, a score exceeding 5.0 was considered an indicator of psychotic 
symptom intensity as it has been shown to separate psychosis patients well from non-
psychotic individuals.28  
 
Statistical Analysis 
All statistical analyses were performed using the Statistical Package for the Social 
Sciences (SPSS), version 14.0 or the R environment for statistical computing 
(http://www.r-project.org). To rule out systematic differences between subjects who did 
or did not participate in the follow-up assessment, drop-out reasons were documented 
and age, sex and BPRS symptom dimension scores29 were compared between the 
groups using t-tests and χ2 tests, respectively. 
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Absolute and relative frequencies were calculated for categorical variables, mean values 
were computed for ordinal-scaled variables. To assess the accuracy of the telephone 
interview, findings from the telephone interview were compared with those from the 
face-to-face interview which was considered the gold standard. Sensitivity, specificity, 
positive and negative predictive value and positive and negative likelihood ratio of the 
telephone interview were computed. Finally, to assess the prognostic accuracy of the 
BSIP, specificity, sensitivity, positive predictive value and negative predictive value 
were calculated. Details regarding the calculation and interpretation of these six 
statistical parameters can be found in Figure 1. 
 
[Figure 1] 
 
Results 
Sample Characteristics 
Among the 263 individuals screened with the BSIP, 39 individuals were classified as 
ARMS–, 117 as ARMS+ and 107 as FEP (Figure 2). Of the ARMS– individuals, five 
(13%) were not contactable and eleven (28%) refused a telephone interview. 
Accordingly, 23 (59%) telephone interviews were conducted. Nine individuals (39%) 
interviewed refused a subsequent outpatient appointment, mainly because of “lack of 
time”. In total, 14 subjects (36%) attended a face-to-face interview. 
 
[Figure 2] 
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Among the 117 ARMS+ individuals, 71 (61%) agreed to take part in the study. Of 
these, 7 individuals (10%) dropped out of the study before a follow-up duration of two 
years and were thus excluded. Accordingly, 64 ARMS+ individuals (55%) were 
included in the analyses. 
There were no significant differences with regard to age, sex or BPRS symptom 
dimension scores between participants and refusers (Table 2). Also, the proportion of 
ARMS– and ARMS+ individuals followed up did not significantly differ between the 
groups (p ≤ 0.976). 
 
[Table 2] 
 
Telephone Interview 
When asked about their emotional wellbeing, 26% (n = 6) of ARMS– individuals felt 
worse, 35% (n = 8) felt better and 39% (n = 9) reported no change in wellbeing since 
the initial assessment. With regard to their capacity to work, 44% (n = 10) reported no 
change, 17% (n = 4) stated that their situation had improved, and 39% (n = 9) indicated 
that it had deteriorated (newly unemployed or receiving disability pension). In total, 
65% (n = 15) had received pharmacotherapy and/or psychotherapy since initial 
assessment. In detail (multiple answers possible), 57% (n = 13) had received 
antidepressants, 22% (n = 5) tranquilisers, 13% (n = 3) antipsychotics, and 9% (n = 2) 
were unsure about their medication type. All individuals with a history of antipsychotic 
medication had received this form of pharmacotherapy for reasons other than psychosis. 
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When examining psychotic symptoms using the BPRS, one individual was suspected to 
have developed psychosis.  
 
Face-to-Face Clinical Interview 
Among the 14 ARMS– individuals who attended the face-to-face interview, none had 
transitioned to psychosis according to BPRS criteria. The mean BPRS total score was 
32 (SD 7), corresponding to an overall psychopathological symptom severity of “mildly 
ill”.30 The average level of functioning as assessed with the GAF was 69 (SD 13), 
representing mild symptoms or some difficulty in social or occupational functioning. 
Clinical diagnoses of ARMS– individuals at follow-up are provided in Table 3. In brief 
(multiple diagnoses possible), the majority of individuals fulfilled criteria for a 
depressive (93%, n = 13) or anxiety disorder (28%, n = 4). The one individual suspected 
to suffer from psychosis on the basis of the telephone interview was diagnosed with 
borderline personality disorder instead. 
 
[Table 3] 
 
Details on self-rated psychotic symptoms are provided in Table 4. Only the participant 
suspected to suffer from psychosis on the basis of the telephone interview scored high 
on all self-rated psychotic symptom dimensions, including “paranoid ideation” and 
“psychoticism” using the SCL-90-R, the paranoid scale of the PDS, and positive 
symptoms as measured with the CAPE. For negative symptoms as assessed with the 
CAPE, she and one other individual (16%) scored above the proposed cut-off value. 
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However, as described above, a diagnosis of psychosis was not confirmed during the 
clinical face-to-face interview. 
 
[Table 4] 
 
Transition to Psychosis in At-Risk Mental State Individuals 
The course of mental health in ARMS+ individuals has previously been described in 
detail by our research group.17, 31 In short, 21 of the 64 ARMS+ subjects developed 
psychosis during the follow-up period (median time until psychosis onset in ARMS+ 
individuals: nine months). 
 
The Accuracy of the Telephone Interview 
According to the telephone interview, one ARMS– individual was suspected to have 
developed psychosis. The subsequent face-to-face clinical interview showed that none 
of the ARMS– individuals had actually developed psychosis. Thus, the specificity of the 
telephone interview was 0.93 (95% CI 0.66, 0.99), the negative predictive value was 
1.00 (95% CI 0.75, 1.00). The sensitivity and positive predictive value could not be 
determined since there were no true positives. 
 
The Prognostic Accuracy of the BSIP 
Given the high accuracy of the telephone interview, findings from it regarding transition 
to psychosis were incorporated into the following analyses if a face-to-face interview 
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had not been feasible. Based on the follow-up assessments of ARMS– and ARMS+ 
participants, the following psychometric properties for the BSIP emerged: The 
sensitivity was 1.00 (95% CI 0.77, 1.00), meaning that all individuals who developed 
psychoses had been correctly identified as ARMS+ individuals at baseline. Specificity 
was 0.35 (95% CI 0.24, 0.48), indicating that the BSIP identifies in 35% of the cases 
correctly who remains unaffected by psychoses. The positive predictive value was 0.33 
(95% CI 0.22, 0.46). That is, 33% ARMS+ individuals had a transition to psychosis 
during follow-up. The negative predictive value was 1.00 (95% CI 0.79, 1.00). That is, 
100% of ARMS– individuals remained non-psychotic within a four-year follow-up 
period. The positive likelihood ratio was 1.54 (95% CI 1.19, 1.83), indicating that 
individuals identified as being in an ARMS according to the BSIP have a significantly 
increased probability of psychosis onset as compared to their pretest probability.  The 
negative likelihood ratio was 0 (95% CI 0), showing that individuals identified as not 
being in an ARMS according to the BSIP have a largely decreased probability of 
psychosis as compared to their pretest probability. . In fact, their probability of 
developing psychosis is estimated to be zero. 
 
Discussion 
In a four-year follow-up of individuals initially classified as not at risk of psychosis 
according to the BSIP, none were found to have developed psychosis. The sensitivity 
(1.00) of the BSIP was excellent, indicating that all individuals who transitioned to 
psychosis were correctly classified as ARMS+. The specificity (0.35) was substantially 
lower since only about one third of ARMS+ subjects transitioned to psychosis during 
the follow-up period. 
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Our finding of an excellent sensitivity of the BSIP is in line with a recent meta-analysis 
that reported similar sensitivity estimates of 0.96 for both the SIPS and CAARMS 
across samples, with no influence of follow-up duration.14 Similarly, Schultze-Lutter et 
al.32 documented a sensitivity of 0.93 when employing both the SIPS and the “cognitive 
disturbances” (COGDIS) symptom criteria of the SPI-A in a four-year follow-up study.  
The specificity of the BSIP is similar to that of the combined SIPS and COGDIS criteria 
of the SPI-A (0.28)32 and the SIPS (0.39), but slightly lower than that of the CAARMS 
(0.56).14 As opposed to the CAARMS however, the BSIP additionally classifies 
individuals as ARMS+ who present with relatively unspecific symptoms and risk 
factors. This fact may account for the observed higher sensitivity but lower specificity 
of the BSIP as compared to the ultra-high risk criteria. Indeed, if those subjects who 
only had low risk according to the BSIP had been classified as ARMS– (analyses not 
shown), the sensitivity of the BSIP would have declined to 0.95 as there would have 
been one false-negative but the specificity would have improved to 0.45. So with the 
extra category of “low risk”, the BSIP ensures not to overlook any individual at risk at 
the cost of identifying slightly more false positives. 
When examining the utility of a specialised telephone interview in assessing psychosis 
onset in ARMS– individuals, a very high validity emerged. The telephone interview 
yielded only one false-positive psychosis classification. Accordingly, it appears to be a 
less resource-demanding and highly valid alternative to face-to-face clinical interviews. 
We recommend to conduct telephone interviews with ARMS– subjects routinely and to 
only invite those individuals with suspected onset of psychosis to a face-to-face 
interview. 
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Our follow-up assessment also provides new insights into the clinical characteristics and 
functional outcome of ARMS– individuals who had been referred to us with suspected 
emerging psychosis. Most ARMS– individuals were diagnosed with major depressive 
and/or anxiety disorders at follow-up. This is well in line with the fact that we, as well 
as other early detection services, found ARMS– individuals to commonly present with 
mood and anxiety disorders at initial contact.33, 34 A recent meta-analysis has shown that 
diagnoses of depressive or anxiety disorders are made in about 41% and 15% of 
ARMS+ individuals at baseline, respectively. As in ARMS+ samples, the spectrum and 
severity of psychopathological symptoms in ARMS– cohorts share strong 
commonalities with other mental disorders35 and the general level of functioning varies 
considerably between subjects.  
A particular quality of this study is the assessment of transition to psychosis in ARMS– 
and ARMS+ individuals after a relatively long follow-up duration of at least two and 
four years, respectively. Moreover, we provide detailed clinical characteristics of 
ARMS– participants at follow-up and fill this gap in the literature. Some limitations 
need to be addressed. First, the sample size of ARMS– individuals was relatively small. 
With only 23 of 39 (59%) ARMS-follow-up interviews that could be conducted, it 
remains unknown whether some individuals who did not take part in the follow-up had 
developed psychosis.  
In conclusion, the BSIP is a valid instrument for early detection of at-risk states for 
psychosis, with an excellent sensitivity and a specificity that is similar to other risk 
assessment instruments. Its advantage if the comparably shorter interview duration. 
Future research should aim at following up individuals seen at early detection services 
and classified as “not at risk” in order to further improve the specificity of risk 
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assessment instruments. Moreover, the specificity can likely be enhanced by combining 
ARMS criteria with additional risk factors and biomarkers from other domains such as 
neuropsychology17, neuroimaging36 or neurophysiology37 into prediction models.
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Tables 
 
Table 1. Domains of the Basel Screening Instrument for Psychosis (BSIP)6 
(1) Psychopathology 
- Prodromal symptoms according to DSM-III (first occurrence within last 5 years and persisting up to now) 
- Other prodromal signs as derived from literature (first occurrence within last 2 years and persisting up to now) 
- Psychotic symptoms (attenuated or brief) 
(2) Social decline 
Marked deterioration of performance with severe consequences for work, education or relationships (occurence during last 5 years and persisting up to now) 
(3) Drug abuse 
Regularly within the last 2 years  
(4) Previous psychiatric history 
Previous psychiatric disorders and treatments 
(5) Genetic risk 
Schizophrenia/psychoses in the family 
(6) At-risk age 
(7) Patient referral because of suspected psychosis 
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Table 2. Sociodemographic and clinical characteristics at baseline 
  At-Risk Mental State  Not At-Risk Mental State 
  All 
(n=117*) 
Followed-up 
(n=64) 
Not followed-
up (n=53) p-value  
All 
(n=39*) 
Followed-up 
(n=23) 
Not followed-
up (n=16) p-value 
Age  26.3 (7.9) 26.2 (8.4) 26.4 (7.4) 0.843  31.5 (8.8) 31.6 (8.6) 31.5 (9.4) 0.909 
Gender:     1.000     0.692 
Women  49 (42%) 27 (42%) 22 (42%)   18 (46%) 10 (43%) 8 (50%)  
Men  68 (58%) 37 (58%) 31 (59%)   21 (54%) 13 (57%) 8 (50%)  
BPRS*:           
Depression/Anxiety  8.65 (3.51) 8.43 (3.66) 9.00 (3.29) 0.410  11.3 (5.01) 12.2 (5.92) 10.2 (3.41) 0.224 
Psychosis/Thought Dist.  7.12 (3.07) 6.70 (2.75) 7.76 (3.45) 0.103  5.76 (2.91) 5.26 (1.91) 6.40 (3.81) 0.304 
Negative Symptoms  5.78 (2.99) 6.03 (3.14) 5.39 (2.72) 0.272  5.57 (2.72) 6.05 (2.91) 4.97 (2.41) 0.243 
Activation   5.90 (2.63) 5.70 (2.52) 6.22 (2.81) 0.338  6.12 (2.51) 6.47 (2.22) 5.67 (2.85) 0.375 
For age, means and standard deviations are provided. For gender, absolute and relative frequencies are provided. BPRS, Brief Psychiatric 
Rating Scale.21 
* For BPRS symptom dimensions, there are 13 missing cases in the At-Risk Mental State group and 3 missing cases in the Not At-Risk 
Mental State group.  
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Table 3. DSM-IV diagnoses of individuals not at risk of psychosis after four-year 
follow-up 
DSM-IV 
Code Diagnosis % (n) 
MOOD DISORDERS 93 (13) 
296.26 Major depressive disorder, single episode, in full remission 21 (3) 
296.31 Major depressive disorder, recurrent, mild 7 (1) 
296.32 Major depressive disorder, recurrent, moderate 7 (1) 
296.34 Major depressive disorder, recurrent, severe, with psychotic features 7 (1) 
296.35 Major depressive disorder, recurrent, in partial remission 14 (2) 
296.36 Major depressive disorder, recurrent, in full remission      21 (3) 
300.04 Dysthymic disorder 7 (1) 
311 Depressive disorder, not otherwise specified 7 (1) 
ANXIETY DISORDERS 28 (4) 
300.22 Agoraphobia, without panic disorder, mild, in partial remission  7 (1) 
300.23 Social phobia, in partial remission 7 (1) 
300.29 Specific phobia, moderate  7 (1) 
300.7 Body dismorphic disorder 7 (1) 
EATING DISORDERS 7 (1) 
307.1 Anorexia nervosa, in full remission 7 (1) 
ADJUSTMENT DISORDERS 7 (1) 
309.4 Adjustment disorder with mixed disturbance of emotions and conduct, in 
full remission 
7 (1) 
SUBSTANCE RELATED DISORDERS 7 (1) 
304.10 Benzodiazepine dependence, in full remission 7 (1) 
PERSONALITY DISORDERS 7 (1) 
301.83 Borderline personality disorder 7 (1) 
DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition, based 
on the Structured Clinical Interview for Axis-I Disorders (SCID).23 Multiple diagnoses 
are possible.  
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Table 4. Symptomatology and global level of functioning of individuals not at risk of psychosis after four-year follow-up 
  SCL-90-R  PDS  CAPE  GAF  BPRS 
Individual  Paranoid 
ideation Psychoticism  
Paranoid 
Scale  
Positive 
symptoms 
Negative 
symptoms   
 Total Score 
1  - -  2  - -  55  41 
2  0.33 0.20  6  2.30 3.79  70  28 
3  0.00 0.00  0  2.20 5.00  90  27 
4  1.00 0.40  1  3.07 5.33  65  28 
5  0.00 0.30  0  2.30 3.21  50  41 
6  3.00 3.33  19  6.16 7.62  55  43 
7  0.17 0.00  0  2.26 2.64  70  25 
8  - -  -  - -  85  24 
9  0.67 0.50  2  - -  60  35 
10  0.50 0.00  3  3.35 4.36  65  38 
11  0.00 0.00  0  2.05 2.36  85  - 
12  0.83 0.40  1  2.75 4.31  65  31 
13  0.33 0.30  0  2.30 3.36  90  26 
14  1.17 1.00  3  2.60 7.00  65  34 
Mean (SD)  0.67 (0.83) 0.54 (0.93)  2.85 (5.16)  2.85 (1.17) 4.45 (1.69)  69.28 (13.28)  32.38 (6.69) 
Bold indicates scores above cut-off value; SD, standard deviation. 
BPRS, Brief Psychotic Rating Scale;21 CAPE, Community Assessment of Psychic Experiences;27 GAF, Global Assessment of 
Functioning;24 PDS, Paranoid-Depression Scale;25 SCL-90-R, 90-item Symptom Checklist – revised.26 
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Figure Legends 
 
Figure 1. Measures of prognostic accuracy. 
Figure 2. Study sample at initial screening and follow-up. BSIP, Basel Screening Instrument for Psychosis.6 
